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Because of its biocompatibility and osteoconductive properties, calcium-phosphate cement has 
been used as bone surrogate. 
Objective: The purpose of this study was to do a histomorphometric comparison of bone regeneration 
using hydroxyapatite biphasic ceramic, calcium-phosphate cement and autogenous bone graft. 
Study Design: Prospective and laboratorial experiment. 
Materials and Methods: Two 5mm in diameter cavities (left and right - test and control) were 
made in the parietal bone of 72 rats. The GI, GII, GIII and GIV test cavities were filled with calcium-
phosphate cement, biphasic ceramic hydroxyapatite, autogenous bone graft and blood. The animals 
were killed at 30, 60 and 90 days and the specimens underwent histomorphometric analysis. 
Results: The results showed that autogenous bone graft treated defects had significantly more new 
bone at 30 days compared to other test groups. Within 60 and 90 days, bone formation was more 
significant in the test groups GI, GII and GIII; GI and GII encompassed larger areas. Throughout 
the evaluation periods, GII tests showed more bone formation when compared to GI. 
Conclusion: Biomaterials depicted a significantly increase in bone content, when compared to 
autogenous bone graft, concerning bone regeneration.
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INTRODUCTION
Bone loss remains as one of the main problems 
within medical and dental specialties, very likely associ-
ated with the exposure of bone tissue to different physi-
ological and pathological situations. Bone tissue has an 
impressive regenerative capacity and, in many situations, 
it is perfectly capable of reestablishing its architectural and 
mechanical properties by means of a complex process 
which involves local and systemic actions. Nonetheless, 
the bone regenerative capacity has limitations and may 
also fail, resulting in usually bone defects which are very 
large to be spontaneously filled in and repairing itself1.
Bone loss caused by fractures, extensive surgery 
and disease processes which involve the stomatognathic 
process, such as osteomyelitis, cystic lesions, dental tumors 
and periodontal bone defects, besides the continuous 
and growing need for osteointegration of bone grafts and 
implants in the receiving and donor sites, have led many 
researchers to develop new techniques aiming at helping 
bone tissue repair or accelerate the bone healing process2,3.
In order to install, recover and/or keep bone 
quality and volume in regions which lost their anatomical 
shape, different studies have tried to develop or improve 
new and promising biocompatible materials with osteocon-
duction properties, which promote bone defect repair4-7. 
In order to do that, these materials must comply with 
some conditions: support must be made of a bioactive or 
bio inert material; its shape and size must promote bone 
growth from inside and bone deposition must happen 
by replacement8. Bone conduction materials are unable 
to induce cell differentiation of osteoblasts, nonetheless, 
they fill out the defect, guiding the new cells originated by 
osteoprogenitor cell proliferation, coming from the margins 
of the defect, as they promote bone neogenesis5,6,7,9,10.
Having in mind the larger material bioavailability, 
morbidity reduction, less surgical time, a greater facility 
to execute the surgery - provided by the filling up of 
osteoconduction material; the goal of the present paper 
is to investigate, through morphometric analysis, the pro-
cess of bone regeneration, carefully measuring the bone 
malformation, influenced by calcium phosphate cement, 
biphasic hydroxyapatite ceramic and by the autogenous 
bone graft in the repair process of critical bone defects, 
made to the skull of Wistar lineage rats.
MATERIALS AND METHODS
This was a prospective, lab experimental, paired 
and blind study, with randomly assessed work groups. The 
animal model was the male Wistar Albinus, rat, weighing 
between 350 and 400 grams, clinically healthy and making 
up a total sample of 72 rats, kept under natural conditions 
of light, moisture and temperature at the animal hous-
ing facility of the Federal University of Campina Grande 
(Campina Grande/Brazil). During the entire experimental 
period, the animals were fed a standard solid diet and ad 
libitum water. The animals were broken down into four 
groups, and each group was further divided into three 
groups, according to observation periods of 30, 60 and 
90 days.
The present study’s protocol was submitted to ap-
proval by the Ethics in Research  with Animals Committee, 
under protocol # 002/09.
Under general anesthesia (Ketamine Chloridrate at 
10% (0.05 ml/100g) and Xylazine Chloridrate at 2% (0.025 
ml/100g), the animals were submitted to antisepsis on the 
site chose for the surgical intervention, the craniofacial 
region, extending side-to-side, between the external ears, 
and anteroposteriorly, the regions of the nasal and occipital 
bones. This way, we made a linear coronal incision, on 
the skin and the subcutaneous tissue, of approximately 1.5 
cm in extension with a complete posterior mucoperiosteal 
shifting until the complete exposure of both parietal bones 
of the animal. Two standardized 5mm bone defects were 
made to the side of the median sagittal suture, with a 4mm 
distance between them, measured by a surgical caliper and 
having as a depth parameter, the bone cortical breakage 
and exposure, without perforation, of the dura mater. The 
left-side bone defect was made more cranially, while the 
contralateral one was more caudal, aiming at reducing the 
likelihood of bone filling material shifting from one bone 
defect to the other at the time of tissue suturing.
After making both bone cavities, only the left-side 
bone cavities were filled out by the biomaterial in the 
external cortical bone, while the right-side bone cavities 
did not receive any filling material, only the blood clot 
from the animal - acting as the control group in the study 
when compared to the filling material and the autogenous 
bone graft. Animals from groups I, II, III and IV had their 
left-side cavities filled out by calcium phosphate (Norian 
CRS Fast Set Putty - Synthes North America Products, Cali-
fornia, United States), by biphasic hydroxyapatite ceramic 
(made up of 40% of hydroxyapatite and 60% of calcium 
phosphate cement) (Genius, Baumer S.A., Campo Largo, 
Paraná, Brazil), and by autogenous bone graft and the 
animal’s own blood clot.
The calcium phosphate cement was prepared ac-
cording to the manufacturer’s instruction, mixing the two 
components: the calcium phosphate as a sterile powder 
(0.25g) and a sterile solvent based on sodium phosphate, 
which made a homogeneous and uniform paste of calcium 
phosphate cement. The biphasic hydroxyapatite ceramic 
(0.25g), because of its microgranular nature, was mixed to 
a small amount of blood obtained from the animal at the 
time of the incision or after the osteotomy needed to form 
the bone defects. The autogenous bone graft was obtained 
from the circular segment of the skull, removed during the 
bone defect making. For such, the circular segment was 
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divided in four smaller pieces, and three were autogenous 
bone fragments inserted into the left bone cavity.
After making it and the proper filling up of the test 
cavity with the biomaterial, a non-resorbable membrane 
was placed (Gen-Derm®, Baumer S.A., Campo Largo, 
Paraná, Brazil) on both the bone cavities made, with the 
intent of avoiding excessive pressure and connective 
tissue invasion of the experimental and control cavities. 
This membrane was cut and fit passively on the rat’s skull, 
without the need to fix it. After membrane insertion and 
fitting, the periosteum, the muscle tissue and the skin of 
the entire animal were repositioned and sutured with nylon 
monofilament wire (4-0).
After the observation periods, the animals were 
slaughtered at 30, 60 and 90 days after surgery, through 
intracardiac administration of potassium chloride, after 
general anesthesia, according to the protocol described 
at the time of the surgery technique, until we noticed the 
termination of vital signs. The skulls from each animal were 
removed, making up the surgical specimens from each 
group. The specimens obtained were dip in 10% buffered 
formalin solution for 02 days, they were later decalcified in 
a 5% nitric oxide solution and routinely processed by the 
hematoxylin-eosin technique, according to the protocol 
established by the buccal pathology lab of the Dentistry 
School of the University of Pernambuco.
The slides were studied under light microscopy. 
The slides from each animal were submitted to microscopic 
exam through the capture system, under 20x magnification 
and image analyses by a set of pixels - Image-Pro Plus®. 
After image capture in JPEG format, they were sent to 
the Image Tool Scripting Language® - histomorphometry 
software. Through this histomorphometric software we 
measured the desired areas, without prior knowledge 
concerning image distribution in their respective study 
groups, by outlining  the desired regions with the mouse, 
thus assessing the bone repair development by measur-
ing the bone neogenesis areas. The values obtained were 
submitted to descriptive and inferential uni and bivariate 
statistical analyses by means of the SPSS for Windows - ver-
sion 15 software, using the Mann-Whitney U test (p≤ 0.05).
RESULTS
Charts 1 and 2 depict the mean values concerning 
the newly created trabeculate bone areas, quantitatively 
analyzed in each group, as well as the observation peri-
ods analyzed from a set of pixels. The histomorphometric 
assessment was calculated a priori, by comparing the 
groups individually by tested material. Among all the 
paired comparisons, the only one which proved significant 
was the test group after 60 days of observation (p=0.000). 
Mann-Whitney U test of paired comparisons showed that 
the difference is in the control group when compared to 
the others, it has a lower histomorphometric value when 
compared to the other materials tested, and throughout 
all the observation periods tested.
Histomorphometric results from the total areas of 
the newly created bone trabeculate showed that the groups 
submitted to bone filling biomaterial (osteoconduction 
and autogenous bone graft) showed bone trabeculate area 
values higher than the control group of the same animal 
and of the experiment’s negative control group (Group 
IV); however, without statistically significant association 
between the groups. Analyzing total osteogenesis, ac-
cording to the different observation periods, we noticed 
homogeneous bone neogenesis between the test and 
control groups at 60 and 90 days. The increase in osteo-
genesis seen during the transition from the 30 to 60 days 
of observation and the osteogenesis maintenance from 60 
to 90 days of observation must be stressed in all the test 
groups submitted to osteoconduction material insertion 
(calcium phosphate cement and biphasic hydroxyapatite 
ceramic) and the autogenous bone graft; however, with 
a greater intensity in the groups submitted to bone filling 
biomaterials (Charts 1 and 2). It is important to stress the 
drop in osteogenesis that happened during the transition 
from 60 to 90 days of observation, in the test cavities, 
concerning all test materials.
As we quantitatively analyze the newly created 
trabeculate bone from each tested material, its respective 
control and test cavities, we noticed statistically significant 
differences in the group submitted to autogenous bone 
graft at 30 days (p=0.016), and the histomorphometric 
value was higher in the test cavity. The second statistically 
significant difference was in the calcium phosphate cement 
group at 60 days (p=0.045), being higher in the bone tra-
beculate areas in the test cavities and the third statistically 
significant difference was in the biphasic hydroxyapatite 
ceramic group at 60 days (p=0.037), also showing higher 
bone neogenesis values in the test group. The values as-
sociated with the test are depicted on Table 1; nonetheless, 
the mean values corresponding to these groups may be 
seen in the previous charts.
When we paired the assessment times with the 
control and test cavities of the materials tested, two situ-
ations were considered statistically significant. The first 
was seen in the transition between 30 and 60 days in the 
calcium phosphate cement group test cavity, in which 
the mean value of the newly formed bone trabeculate 
was higher at 60 days; the second statistically significant 
difference was seen in the test cavity of the biphasic 
hydroxyapatite ceramic group during the 30 to 90 day 
combination period, and the histomorphometric mean 
values were higher at 90 days (Table 1 for inference tests 
and Charts 1 and 2 for descriptive statistics).
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Chart 1. Control and test groups’ histomorphometric evaluation by assessment of time and according to the material tested. - Blue: 30 days, 
Red: 60 days, Green: 90 days.
Chart 2. Histomorphometric assessment according to the test and control groups’ mean values, by evaluation time and according to the material 
tested. Blue: 30 days; Red: 60 days; and Green: 90 days.
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DISCUSSION
Numerous biomaterials are constantly being stud-
ied in order to find one to replace bone tissue, so as to 
provide a feasible alternative for the autogenous bone graft 
which, although being the best and better accepted bone 
substitute - for having essential characteristics of osteoin-
duction, osteoconduction and osteoprogenicity4,11,12, it has 
disadvantages, especially considering morbidity because 
of the need for bone removal from the donor area and its 
insertion in the receiving area, thus increasing the number 
of surgical interventions, besides the amount of bone graft 
available, especially in cases of intraoral donor areas13-15. 
We also noticed different degrees of post-op bone resorp-
tion, changing the previously obtained results16.
The biomaterial used as bone surrogate must 
be biocompatible, atoxic, resist deformation, resorption 
resistant or not according to the decided application and, 
should they be resorbable, they must be metabolized 
by the body or excreted through normal physiological 
pathways3,5-7,14,15.
The calcium phosphate bioceramic continue being 
studied and utilized in tissue reconstruction procedures, 
having seen that their physicochemical characteristics 
and properties are able to induce a favorable biological 
response. The calcium phosphate bioceramics have bio-
compatibility, bioactivity and osteoconduction properties, 
which shows that as they are inserted in the receiving 
bed, they do not cause immune responses, they are able 
to connect directly to the bone tissue and enable bone 
growth throughout its surface4,17. The characteristics seen 
in both bone filling materials, the biphasic hydroxyapatite 
ceramic (Gen-Phos® HA TCP, Genius, Baumer, Inc.) and 
the calcium phosphate cement (Norian CRS®, Synthes 
GmbH & CO, KG), corroborate the conceptually necessary 
properties for an ideal biomaterial, since they do not cause 
exacerbated inflammatory reaction, were not encapsulated 
or rejected by the body and enabled the osteoprogenitor 
cells adjacent to the bone defect to differentiate through 
the framework generated by such materials, proving os-
teoconduction5,6,7,9,10.
The methodology employed in the present study is 
in agreement with the one employed by numerous  studies 
aiming at assessing the behavior of bone filling materi-
als18-21. Since the sample subject chosen were young male 
adult wistar rats, the sample inclusion criterion aimed at 
avoiding the interference of hormonal factors and guar-
antee  increased physiological and metabolic conditions 
in young rodents.
Rats have been used as experimental models in 
order to assess bone scaring. Thus, the scar response has 
been documented under a variety of conditions. Rats’ 
laminar and long bones have a layer of densely mineral-
ized and well-formed cortical bone, which do not suffer 
internal remodeling and, consequently, are very fit to 
bone kinetics studies. Prior studies have been reported in 
a six-day alveolar bone remodeling for rats, compared at 
60 and 120 days for human adults22.
As surgical sites, we chose to make the two circu-
lar defects laterally to the median sagittal suture, in the rats’ 
skulls. The circular defect diameter was 5mm, which was 
the diameter considered critical for bone regeneration23,24. 
According to Schmitz & Hollinger25, the critical defect has 
an area which prevents spontaneous bone regeneration, 
unless another osteogenic, osteoconduction or osteoinduc-
tion material is inserted inside or over the bone defect. As 
to the creation of two bone cavities in the same animal, 
the present paper was based on the studies carried out 
by Bosch et al.23, Grandi18 and León21, which stated that 
the creation of two spherical cavities on the rats’ skulls 
create a paired study model, proper to assess the efficacy 
of the osteogenesis promoter materials used to stimulate 
bone regeneration.
According to the data obtained with bone re-
generation, it is not possible to assess whether the 5mm 
defect behaves as critical, having seen that there was bone 
neogenesis in the group which did not receive bone fill-
ing material, receiving only blood clot in the bone defect 
(control group of the test animals and negative controls). 
The bone regeneration seen in the control groups (control 
group of test animals and negative controls), is different 
from those in the studies by Bosch et al.23, as well as those 
from Donos et al.24, which proved that the 5mm defects 
on the rats’ skulls would not promote any spontaneous 
bone regeneration sign after 30 or 60 days of observation.
It is necessary to consider the anatomical relation 
which exists between the parietal bone morphology, bone 
site chosen for the bone defect, and the bone regenera-
tion process developed along the observation periods. 
It is known that the parietal bone is our laminar bone, 
predominantly cortical and with little medullary compo-
Table 1. Test and control groups’ histomorphometric assess-
ment by assessment time and according to the tested material.
Group
Assessment 
time 
(in days)
GI GII GIII GIV
Control
30 and 60 p=0,337 p=0,936 p=0,172 p=0,628
60 and 90 p=0,337 p=0,872 p=0,631 p=0,872
30 and 90 p=0,631 p=0,747 p=0,423 p=0,810
Test
30 and 60 p=0,016* p=0,337 p=0,521 p=0,631
60 and 90 p=0,337 p=0,873 p=0,423 p=0,749
30 and 90 p=0,936 p=0,016* p=0,748 p=1,000
(p) Statistical association
(*) has statistically significant difference for p≤0.05.
Source: Research data, 2010.
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nent26. As we created the bone defect, it involved the 
bone’s internal and external corticals, without perforating 
the meninges, especially the dura mater. From then, we 
observe that the only direction of the osteogenesis would 
be the one induced from the borders of the bone defect 
on the skull24,27. It is also known that the external and 
internal corticals from the laminar bones are internally 
and externally coated by connective membrane layers, 
called periosteum and endosteum26,27. Thus, it was sug-
gested that the bone regeneration process presented by 
the negative control group (GIV) could be favored by the 
differentiation of the osteogenic cells found in the perios-
teum, repositioned at the time of the wound closure, as 
well as the endosteum, preserved in the vicinities of the 
defect borders, as per advocated by Dângelo & Fattini26 
and Takeuchi et al.27.
The histomorphometric analyses we made enabled 
us to detect the presence of bone in the defect and to quan-
tify the size of the newly formed area. The importance of 
this type of analysis has been confirmed in the studies by 
Ferreira da Silva20, Cavalcanti et al.28, Grandi18 and León21, 
who reported that quantitative analysis was essential for 
studies which aimed at assessing the effectiveness of new 
treatment modalities concerning bone neogenesis.
Upon observing bone neogenesis, from the quanti-
tative viewpoint, the results obtained from this experiment 
show differences between the control and test groups, 
concerning the different bone filling material utilized, as 
well as between these groups and the negative control 
group. Larger bone trabeculae areas were seen in the test 
cavities of the groups submitted to bone filling material; 
however, without statistically significant association at 30 
and 90 days, which showed the biphasic hydroxyapatite 
ceramic, calcium phosphate cement and autogenous bone 
graft positive action on the bone repair process. These 
results are in agreement with those from Ferreira da Silva20, 
Cavalcanti et al.28, Grandi18 and León21, who also found 
an increase in bone neogenesis considering bone filling 
material in relation to the control cavities, using software 
for image analysis and later morphometric studies.
As we quantitatively analyze the mean values of 
newly formed bone trabeculae, according to the observa-
tion periods, we noticed that the animal model utilized in 
the study had higher rates of bone formation at 60 days, 
with homogeneous and superior bone neogenesis values 
among the test groups submitted to the different bone 
filling materials tested and the negative control group, 
with a statistically significant association. At 90 days of 
the experiment, we noticed a drop in osteogenesis levels 
in the test cavities from the different materials tested. 
Throughout all the observation periods and considering 
the different materials tested, we noticed a larger area of 
bone neogenesis in the test cavities when compared to 
their control counterparts - which were filled out only by 
the blood clot from the animal. This mild reduction in bone 
neogenesis area at 90 days in all the test cavities from the 
different materials utilized, suggested that the bone repair 
process was within a degree of bone maturing progression, 
which is in agreement with the studied led by Kurashina 
et al.29, who stated that the observation period progression 
does not cause area size increase, but rather in the bone 
trabeculate maturation degree.
As to the behavior of the bone surrogates in 
relation to bone neogenesis, we noticed that the areas 
of bone trabeculate newly formed by the hydroxyapatite 
biphasic ceramic were similar and larger than those newly 
formed by the autogenous bone graft at 60 and 90 days, 
respectively, showing that such materials are favorable to 
osteogenic cells, which is in agreement with the studies 
led by Grandi18 and Tsai et al.30 and disagrees with those 
from Cavalcanti et al.28, which state that autogenous bone 
grafts yield better bone neogenesis.
When we studied the chemical makeup of the 
bioceramic utilized, we could see that that the calcium 
phosphate cement and the biphasic hydroxyapatite ce-
ramic particles were well differentiated as to particle size, 
expressing larger hydroxyapatite biphasic ceramic par-
ticles, with diameters varying between 0.5 and 0.75mm. 
The calcium phosphate cement was used as a powder, 
being converted into a paste after manipulation. The in-
crease in crystal size may influence its maintenance period 
within the bone defect, with direct impact on the bone 
neogenesis modulation, considering the large osteocon-
duction potential presented by the biphasic hydroxyapatite 
ceramic, following manufacturer’s instructions. Thus, one 
can justify a greater bone trabeculate neogenesis, accord-
ing to morphometric standards, in the test group of the 
animals submitted to the biphasic hydroxyapatite ceramic, 
in all observation periods, when compared to the calcium 
phosphate cement.
In the morphometric results obtained from the 
control and test cavities, from the different materials 
tested, we noticed a statistically significant association in 
three situations only: at 30 days in the autogenous bone 
graft group and at 60 days for the calcium phosphate and 
biphasic hydroxyapatite ceramic. We noticed that the 
morphometric data from each study group did not follow 
a homogeneous distribution as far as bone neogenesis 
is concerned, and there were major differences between 
bone neogenesis mean values among animals from the 
same group,  thus the non-parametric inference for data 
evaluation using the median value for inferential assess-
ments. Such behavior variability between animals from 
the same group can be justified with the studies led by 
Garcia & Albergaria-Barbosa13, which advocated that the 
grafts may suffer changes during the demineralization and 
freeze-drying processes, and there is the possible failure 
in standardization considering the laboratorial preparation 
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of the grafts utilized, which may all be considered factors 
leading to the different results found between animals of 
the same group.
It is known that the calcium phosphate cement 
acts as an osteoconduction biomaterial which in its pure 
form is converted into hydroxyapatite cement, with the 
same properties found in the intact bone. It is in this 
hydroxyapatite conversion process, in which the crystals 
remain trapped inside the tissue, that osteoconduction 
is fostered5,6,7,9,10,31. The biphasic hydroxyapatite ceramic 
behaves in a very different way, promoting neogenesis of 
bone cells, while the autogenous bone works as osteoin-
duction, osteoconduction and osteoprogenitor10,29. Having 
the morphometric results obtained from the sample stud-
ied, we can state that both the calcium phosphate cement 
as well as the biphasic hydroxyapatite ceramic behaves as 
osteoconduction materials, since the particles from these 
materials enable the creation of a framework for the de-
position of the osteoinduction cells present in the body.
Based on the morphometric results obtained and 
linking them to the chemical makeup of the bioceramic, 
it is believed that the calcium phosphate cement and 
the biphasic hydroxyapatite ceramic have the necessary 
characteristics for clinical use. Nonetheless, it is important 
to understand the goal intended with the application of 
each one of these materials. In cases when more bone 
volume is needed, with greater demands concerning bone 
quality, i.e. correction of defects impacting cosmetics, the 
biphasic calcium phosphate ceramic can be indicated, 
given the lingering of its particles, providing the necessary 
osteoconduction for the body’s osteoprogenitor cells, hav-
ing seen the increase in biphasic hydroxyapatite ceramic 
particles which enables a greater framework time for the 
aforementioned cells. For the cases in which goal is the 
early neogenesis of bone tissue only, i.e. grafting prior 
to dental implants, the calcium phosphate cement offers 
faster bone neogenesis with material resorption.
The future of bone surrogates must involve re-
sorbable biological implants, developed with a porous, 
tridimensional framework, made from resorbable material, 
filled with morphogenetic proteins and osteoprogenitor 
cells. A time-dependent controlled resorption of the frame-
work would release the bioactive factors trapped inside 
its structures, which would induce transplanted and host 
cells to grow in this intertwining tridimensional pattern. 
Bone would be formed through the framework and not 
on the surface only19.
CONCLUSION
Based on the results achieved, we can vouch for 
the superior bone neogenesis promoted by the biphasic 
hydroxyapatite ceramic and the calcium phosphate cement 
when compared to the autogenous bone graft, and such 
fact places the bioceramics as surgical aides in maxillofacial 
procedures which require bone grafts.
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